// App-Quantinova.ai

TPS4585 : ECOG 8141: A prospective phase II trial of neoadjuvant systemic chemotherapy followed by extirpative surgery for patients with high grade upper tract urothelial carcinoma.

Researchers

Presenter

  • Jean H. Hoffman-Censits

Principal Investigators

  • Vitaly Margulis

  • Noah M. Hahn

  • Edouard John Trabulsi

  • Allison Beaver

  • Elizabeth R. Plimack

Medical Centers

  • The Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, PA

  • The University of Texas Southwestern Medical Center, Dallas, TX

  • The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD

  • Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA

  • Fox Chase Cancer Center, Philadelphia, PA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bladder Cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Carboplatin

  • Gemcitabine

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • II

Study Id's

  • NCT02412670

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved